Trial Profile
Retrospective controlled cohort study of Trastuzumab in treatment of metastatic breast cancer after failure in adjuvant setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Dec 2015 New trial record